Back to search

National and Kapodistrian University of Athens

Μελέτη της προθυμοσίνης α με τη χρήση ειδικών ραδιοεπισημασμένων παραγώγων του μορίου σε in vitro και in vivo τεχνικές

Abstract

dc:description

Prothymosin alpha (ProTα) is a conserved mammalian polypeptide (human sequence 109amino acid-long) exerting a pleiotropic immunoenhancing activity. The N-terminal fragment[1-28] of the molecule, which is identical with the immunostimulating peptide thymosin α1(Tα1), was earlier considered as the immunoactive region of the polypeptide; however,recent data suggest that ProTα may exert a discrete immunomodulating action through itsC-terminal decapeptide [100-109] or its central region [51-89], via targeting Toll-likereceptor- 4 (TLR4). In the frame of this work, a derivative of the C-terminal fragmentProTα[100-109] (ProTα-D1) that can be radiolabeled with 99mTc was developed. Thebiological activity of the non-radioactive 185/187rhenium-complex of this derivative([Re]ProTα-D1, structurally similar with [99mTc]ProTα-D1) was evaluated in suitable in vitrobioassays and in assays correlated with TLR4 surface expression using humanneutrophils, in comparison with intact ProTα, various synthetic ProTα fragments/derivatives and negative control peptides. Subsequent cell-binding studies revealed specific, time-dependent and saturable binding of [99mTc]ProTα-D1 on neutrophils, which was inhibited by intact ProTα and the synthetic ProTα[100-109], as well as by a “prototype” TLR4-ligand (lipopolysaccharide from Escherichia coli, LPS), but not by synthetic Τα1, the central ProTα region and negative control peptides. Our results support the existence of ProTα-binding sites on human neutrophils, recognizing the C-terminal region [100-109], which might involve TLR4. Due to the properties of the radioisotope used for the labeling, [99mTc]ProTα-D1 was further evaluated in in vivo biodistribution and whole body imaging studies in mice bearing an inflammation model. These studies provided important information related to the pharmacokinetic profile of [99mTc]ProTα-D1 but above all revealed the capacity of [99mTc]ProTα-D1 to selectively target inflammatory loci in vivo.The accumulation of [99mTc]ProTα-D1 in inflammatory sites is specific and due to thepresence of the C-terminal decapeptide ProTα[100-109]. Overall, the present thesissignificantly contributed to the enrichment of our basic knowledge on the extracellularmode of action of ProTα, both in vitro and in vivo. Additionally, such data will facilitatefuture exploitation of the polypeptide or a smaller active fragment thereof, such as ProTα[100-109], in the clinical setting.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2015

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Karachaliou, Chrysoula-Evangelia
  • Καραχάλιου, Χρυσούλα-Ευαγγελία

Subjects

dc:subject × 16

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/44026

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Karachaliou, Chrysoula-Evangelia; Καραχάλιου, Χρυσούλα-Ευαγγελία. Μελέτη της προθυμοσίνης α με τη χρήση ειδικών ραδιοεπισημασμένων παραγώγων του μορίου σε in vitro και in vivo τεχνικές. National and Kapodistrian University of Athens, 2015. http://hdl.handle.net/10442/hedi/44026